4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001960048-26-000015
SVP, Finance & CAO sold 3,000 shares at an average $60.92 ($182,753)
- SVP, Finance & CAO acquired 3,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Cowan Elvia · SVP, Finance & CAO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,000 | $25.92 | $77,760 | 30,860 | D |
| 2026-11-02 | Sale : show line 2 in the form 10b5-1 | −2,414 | $60.77 | $146,687 | 28,446 | D |
| 2026-11-02 | Sale : show line 3 in the form 10b5-1 | −586 | $61.55 | $36,067 | 27,860 | D |
| Open-market sales · 3,000 sh · avg $60.92 · $182,753 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-02 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) | −3,000 | 71,068 | D |
Loading xslF345X06/wk-form4_1793829138.xml…